IFNG and neoplasm: These cells can promote tumour progression through immunosuppressive activities and angiogenesis but also mediate anti-tumour immune responses through the use of immune cells in the tumour environment or by directly converting to the Th1 phenotype and producing interferon-γ (IFN-γ) [47].